Skip to content
FY'25FY'24FY'23FY'22
Profitability
Gross margin79.4%+3.7pp75.7%+3.0pp72.6%+2.5pp70.1%-4.0pp
Operating margin2.6%13%
Net margin1%6.2%
EBITDA margin15.2%24.2%
Free cash flow margin18.8%-6.7pp25.5%+4.8pp20.7%+3.4pp17.3%+2.5pp
Returns
Return on equity1%5.1%
Return on assets0.5%2.6%
Return on invested capital1.9%6.3%
Efficiency
Asset turnover0.5×+0.1×0.4×0.0×0.4×+0.1×0.4×0.0×
Inventory turnover1.1×-0.4×1.5×-0.4×1.8×-0.2×+0.3×
Liquidity
Current ratio4.5×+2.1×2.4×-2.8×5.2×+1.9×3.4×+1.7×
Quick ratio3.3×+1.3×-2.2×4.2×+1.4×2.7×+1.2×
Cash ratio1.3×+0.4×0.9×-0.7×1.6×+0.9×0.7×-0.4×
Leverage
Debt-to-equity0.6×-0.1×0.7×+0.5×0.2×-0.2×0.4×-0.6×
Debt-to-assets0.3×0.0×0.4×+0.2×0.1×-0.1×0.2×-0.2×
Net debt / EBITDA2.4×0.2×
Interest coverage1.1×4.3×
Per Share
Book value per share$15.39-8.6%$16.83+0.5%$16.74+0.5%$16.65+4.0%
Valuation
Market capitalization$942.78M-14.5%$869.9M-44.5%$1.57B-11.6%$1.77B-33.9%
Enterprise value$1.21B+2.6%$1.15B-27.9%$1.6B-19.6%$1.99B-30.3%
Price / earnings183.5×37.3×
Price / sales1.3×-0.3×1.2×-1.1×2.3×-0.3×2.7×-2.3×
Price / book1.5×+0.1×1.1×-0.7×1.8×-0.5×2.3×-1.4×
EV / EBITDA10.6×9.8×
EV / sales1.7×0.0×1.6×-0.7×2.4×-0.6×-2.3×
Free cash flow yield13.8%-0.4pp20.5%+11.6pp8.9%+2.4pp6.5%+3.5pp
Earnings yield0.5%2.7%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Pacira BioSciences, Inc.'s profit margins?
Pacira BioSciences, Inc. (PCRX) runs a 79.3% gross margin and a 3.3% operating margin, with a 0.7% net margin.
Where do Pacira BioSciences, Inc.'s ratios come from?
Every ratio is computed from Pacira BioSciences, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.